Friday, March 24, 2017 1:09:41 AM
1. There is no % measurement in preclinical efficacy study - which is not conducted on human beings but on human tissues so there for it cannot measure any percentage .
The reduction of sizable amount of biological inflammation markers related to psoriasis IS THE BIG BREAKTHROUGH ! So far no one was able such and this is what the preclinical studies are all about .
The fact that the company is not making BS statements is because they care about us , the investors , and want to stay transparent and accurate
2. People are looking at the last Q representing the Quarter ended on 9/30/16 and throwing BS. At that time the company was RAISING money and now the company HAVE money ( over 2mm$ and no convertibles notes - so no toxic dilution is expected).
3. Kodiak or its assignee "old nation " have 0 shares . They dumped it to the market already in September 2016
The fact
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM